Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;23(5):536-541.
doi: 10.7499/j.issn.1008-8830.2102045.

[Research advances in the role of ferroptosis in neonatal hypoxic-ischemic brain damage]

[Article in Chinese]
Kai-Yi Zhu  1 , Ming-Yan Hei  1
Affiliations
Review

[Research advances in the role of ferroptosis in neonatal hypoxic-ischemic brain damage]

[Article in Chinese]
Kai-Yi Zhu et al. Zhongguo Dang Dai Er Ke Za Zhi. 2021 May.

Abstract
in English, Chinese

Neonatal hypoxic-ischemic brain damage (HIBD) remains an important cause of neonatal death and disability in infants and young children, but it has a complex mechanism and lacks specific treatment methods. As a new type of programmed cell death, ferroptosis has gradually attracted more and more attention as a new therapeutic target. This article reviews the research advances in abnormal iron metabolism, glutamate antiporter dysfunction, and abnormal lipid peroxide regulation which are closely associated with ferroptosis and HIBD.

新生儿缺氧缺血性脑损伤是导致新生儿死亡和婴幼儿伤残的常见病因，但机制复杂，缺乏特异治疗手段。铁死亡作为一种新型程序性细胞死亡方式，已成为一种新的治疗靶点而逐渐在临床上引起重视。该文围绕与铁死亡及缺氧缺血性脑损伤均密切相关的铁代谢异常、胱氨酸/谷氨酸反向转运体功能异常和脂质过氧化物调控异常的研究进展进行综述。

PubMed Disclaimer

Figures

1
1
铁死亡在HIBD中的作用机制假设示意图
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Finder M, Boylan GB, Twomey D, et al. Two-year neurodevelopmental outcomes after mild hypoxic ischemic encephalopathy in the era of therapeutic hypothermia. JAMA Pediatr. 2020;174(1):48–55. doi: 10.1001/jamapediatrics.2019.4011. [Finder M, Boylan GB, Twomey D, et al. Two-year neurodevelopmental outcomes after mild hypoxic ischemic encephalopathy in the era of therapeutic hypothermia[J]. JAMA Pediatr, 2020, 174(1): 48-55.] - DOI - PMC - PubMed
    1. Disdier C, Stonestreet BS. Hypoxic-ischemic-related cerebrovascular changes and potential therapeutic strategies in the neonatal brain. J Neurosci Res. 2020;98(7):1468–1484. doi: 10.1002/jnr.24590. [Disdier C, Stonestreet BS. Hypoxic-ischemic-related cerebrovascular changes and potential therapeutic strategies in the neonatal brain[J]. J Neurosci Res, 2020, 98(7): 1468-1484.] - DOI - PMC - PubMed
    1. Juul SE, Comstock BA, Heagerty PJ, et al. High-dose erythropoietin for asphyxia and encephalopathy (HEAL): a randomized controlled trial-background, aims, and study protocol. Neonatology. 2018;113(4):331–338. doi: 10.1159/000486820. [Juul SE, Comstock BA, Heagerty PJ, et al. High-dose erythropoietin for asphyxia and encephalopathy (HEAL): a randomized controlled trial-background, aims, and study protocol[J]. Neonatology, 2018, 113(4): 331-338.] - DOI - PMC - PubMed
    1. Wu YN, Song J, Wang YF, et al. The potential role of ferroptosis in neonatal brain injury. Front Neurosci. 2019;13:115. doi: 10.3389/fnins.2019.00115. [Wu YN, Song J, Wang YF, et al. The potential role of ferroptosis in neonatal brain injury[J]. Front Neurosci, 2019, 13: 115.] - DOI - PMC - PubMed
    1. Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. doi: 10.1038/s41419-020-2298-2. [Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future[J]. Cell Death Dis, 2020, 11(2): 88.] - DOI - PMC - PubMed

LinkOut - more resources